TPG Group Holdings (SBS) Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

TPG Group Holdings (SBS) Advisors’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,053,692	Closed	-$28.4M	–	40
2014 Q4	$28.4M	Hold	1,053,692	–	–	0.17%	18
2014 Q3	$12.4M	Hold	1,053,692	–	–	0.08%	30
2014 Q2	$16.4M	Hold	1,053,692	–	–	0.1%	20
2014 Q1	$20.7M	Hold	1,053,692	–	–	0.22%	18
2013 Q4	$17.7M	Buy	+1,053,692	New	+$13.1M	0.21%	19

Other funds holding FPRX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors's FPRX Position: Q1 2015 in Review

TPG Group Holdings (SBS) Advisors sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2015, closing a stake of 1,053,692 shares — an estimated $28.4M sold.

TPG Group Holdings (SBS) Advisors first reported a position in FPRX in Q4 2013 and held it in 5 quarters. The position peaked at $28.4M in Q4 2014. 93 funds tracked by Wall St. Rank hold FPRX as of Q1 2015.

TPG Group Holdings (SBS) Advisors reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2015 after selling out during the quarter.
TPG Group Holdings (SBS) Advisors sold 1,053,692 Five Prime Therapeutics, Inc. shares in Q1 2015, an estimated $28.4M.
TPG Group Holdings (SBS) Advisors first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and held it in 5 quarters.
TPG Group Holdings (SBS) Advisors's Five Prime Therapeutics, Inc. position peaked at $28.4M in Q4 2014.
93 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2015.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q1 2015, filed 15 May 2015.